| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
2 companies
Cohen Chad M serves as a Director at GRND and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 81 sells. Those positions are worth an estimated $1.0M at current prices.
Historically, Cohen Chad M's trades have earned a strong insider score of 87/100 across 19 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +73.4%.
The biggest single holding is ADPT (~$539K) as Chief Financial Officer. The recent filings there lean toward selling, a net 943,375 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 15,000 | $24.58 | $368,678.52 | -71.5% | |
| Feb 10, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 20,000 | $31.52 | $630,308.34 | -51.7% | |
| Jan 8, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Sale+OE | 20,000 | $29.87 | $597,400.00 | -95.2% | |
| Jul 1, 2019 | ADPT Adaptive Biotechnologies Corp | Chief Financial Officer | Buy | 1,000 | $20.00 | $20,000.00 | New |